CDK9 activity in cardiac tissue has been known for its transcriptional suppression of genes required for normal mitochondrial function, such as PGC‐1α and its downstream effectors, resulting in cardiac hypertrophy (Sano et al., 2004; Ventura‐Clapier et al., 2008). Here, CDK9 is linked to cardiac hypertrophy.